Variable | n | QTc Interval, ms | t | p |
---|---|---|---|---|
QTBAZ | ||||
Sex | ||||
Women | 80 | 426.7 ± 21.0 | 2.733 | 0.007** |
Men | 32 | 414.2 ± 23.9 | ||
Ischemic heart disease | ||||
Yes | 12 | 438.2 ± 22.3 | 2.503 | 0.014* |
No | 100 | 421.4 ± 22.0 | ||
β blocker | ||||
Yes | 22 | 415.6 ± 19.5 | −1.775 | 0.079 |
No | 90 | 425.0 ± 22.9 | ||
HCQ | ||||
Yes | 22 | 433.5 ± 22.1 | 2.448 | 0.016* |
No | 90 | 420.6 ± 21.8 | ||
QTFHS | ||||
Sex | ||||
Women | 80 | 414.8 ± 17.3 | 2.103 | 0.038* |
Men | 32 | 407.0 ± 18.8 | ||
Ischemic heart disease | ||||
Yes | 12 | 430.8 ± 17.3 | 3.948 | < 0.001** |
No | 100 | 410.4 ± 16.9 | ||
Hypercholesterolemia | ||||
Yes | 16 | 424.0 ± 23.9 | 2.840 | 0.005** |
No | 96 | 410.6 ± 16.2 | ||
HTN | ||||
Yes | 24 | 412.5 ± 13.6 | −0. 011 | 0.071 |
No | 88 | 412.6 ± 19.1 | ||
OA | ||||
Yes | 44 | 416.1 ± 18.0 | 1.719 | 0.088 |
No | 68 | 410.2 ± 17.7 | ||
Proton pump inhibitor | ||||
Yes | 22 | 418.8 ± 18.9 | 1.847 | 0.067 |
No | 90 | 411.0 ± 17.5 | ||
HCQ | ||||
Yes | 22 | 420.4 ± 16.6 | 2.336 | 0.021* |
No | 90 | 410.6 ± 17.9 | ||
RF-positive | ||||
Yes | 87 | 414.1 ± 18.7 | 1.749 | 0.083 |
No | 25 | 407.0 ± 14.2 | ||
Anti-CCP–positive | ||||
Yes | 77 | 413.7 ± 18.5 | 2.016 | 0.053 |
No | 28 | 406.1 ± 18.5 |